Viewing nowArovan Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 200708458 · Approved 2007.07.23 · Insurance code 649401300
Improvement of hyperlipidemia, prevention of cardiovascular disease (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of heart and cerebrovascular diseases such as myocardial infarction and stroke, and is effective in preventing complications after vascular interventions and alleviating the risk of chronic stable angina. It also lowers the risk of cardiovascular disease in patients with type 2 diabetes who have cardiovascular risk factors. For patients with hyperlipidemia, it helps reduce total cholesterol, LDL-cholesterol, and triglyceride levels while increasing HDL-cholesterol levels. This medication is particularly effective in pediatric patients with heterozygous familial hypercholesterolemia and improves blood lipid levels when controlled solely by diet is insufficient. Therefore, it is used to manage cardiovascular diseases and hyperlipidemia.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on the use of doses higher than 20 mg of this drug in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle problems, so if severe muscle pain or weakness occurs, treatment should be immediately discontinued and consultation with a physician is required. This medication should not be used in patients with certain liver diseases or muscle disorders, in women who are pregnant or may become pregnant, and in children under 10 years of age. Patients with impaired liver or kidney function, individuals who consume alcohol excessively, and the elderly should be particularly cautious while taking this medication and should undergo regular tests as directed by their physician. If any symptoms of liver dysfunction (e.g., fatigue, jaundice, nausea, vomiting) occur while taking this medication, notify a doctor immediately. This medication can interact with other drugs, so particularly when taken with certain antibiotics, antifungals, HIV treatments, some heart medications, grapefruit juice, etc., consultation with a physician or pharmacist is necessary. Women of childbearing potential should use appropriate contraceptive measures while taking this medication and should discontinue if pregnancy is confirmed. This medication is not recommended for nursing mothers and should not be taken while breastfeeding. If symptoms such as muscle pain, muscle weakness, fever, malaise occur during treatment, notify medical personnel immediately and, if necessary, blood tests should be conducted to check for muscle damage. There is no specific antidote for overdose; treatment should be conducted according to symptoms, and regular liver function tests and blood tests are required. Keep out of reach of children, and store the medication in its original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that is not affected by air or humidity. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius (room temperature). Proper storage can help maintain the medication's effectiveness longer.
White, round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 10.85mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.